![](/images/2013/post-sep.jpg)
Kraig Biocraft Laboratories Significantly Increases Spider Silk Reeling Efficiency, Boosting Per Cocoon Yield
/EIN News/ -- ANN ARBOR, Mich., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has further boosted spider silk production with the introduction of new silk cocoon reeling protocols resulting in higher silk yields.
Under the guidance of renowned sericulture expert, Dr. Nirmal Kumar, the Kraig Labs production team modified the processing of its finished silk cocoons, increasing total silk yields per cocoon and improving reeling performance. These mechanical changes to the processing and handling of the Company's spider silk cocoons resulted in a near doubling of reeling efficiency compared to the prior production runs.
"Increasing processing efficiency and cocoon yield was one of Kraig's top three goals for increasing production," said Company founder and CEO, Kim Thompson. "Congratulations to the production team for these dramatic improvements. We anticipated many more months of work before seeing these results. Now we can focus on increasing individual cocoon size, and overall production volumes. I believe that even further gains in possessing yield can be achieved over the next two production cycles."
Dr. Nirmal Kumar and the Kraig Labs production team harvested the third production cycle of its proprietary spider silk cocoon last week. The BAM-1 hybrid cocoons have now been processed under the direction of Dr. Nirmal Kumar and the newly implemented enhanced protocols. In addition to finished reeling spider silk, the team has collected, analyzed, and selected the top performing BAM-1 parent line cocoons for production expansion this fall. Over the next week, selective matings of these top-performing moths will be used to create the next generation of BAM-1 parental line and BAM-1 production hybrids.
"Dr. Nirmal Kumar has evolved our operations at an incredible pace, bringing nuanced details and innovative troubleshooting that has netted outsized returns at a rapid pace," said Company COO, Jon Rice. "These small details and tweaks in processing the finished cocoons have yielded huge improvements in finished silk yield. Undoubtedly, his continued guidance will play a major role in our continuing expansion of production."
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
A photo accompany this release is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b5555a2e-18e5-4d25-8693-e55f1dde4b0d
![](https://ml.globenewswire.com/media/YjBhM2ZjNDUtOTNjYS00YjI3LThkNjctODcyNTViNDY3ZWNmLTUwMDA3MTM0NQ==/tiny/Kraig-Biocraft-Laboratories.png)
![](https://trade.einnews.com/tracking/article.gif?aid=738314645§ion=globenewswire&a=6XL7SN4gNuZzghS_&i=8EQiyeUdwrcduCXi)
Distribution channels: Media, Advertising & PR, Technology ...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release